Decreased sarcoplasmic reticulum phospholipids in human skeletal muscle are associated with metabolic syndrome
Journal of Lipid Research · 2024-03 · 65 (3) · 100519
DOI: 10.1016/j.jlr.2024.100519 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2024-03. Verfasst von Samantha E Adamson und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Metabolism & Lipid Research, Washington University, St Louis, MO, USA. Hauptthemen laut MEDLINE: Insulin Resistance, Metabolic Syndrome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS, NIH.
Abstract (Originalsprache)
Metabolic syndrome affects more than one in three adults and is associated with increased risk of diabetes, cardiovascular disease, and all-cause mortality. Muscle insulin resistance is a major contributor to the development of the metabolic syndrome. Studies in mice have linked skeletal muscle sarcoplasmic reticulum (SR) phospholipid composition to sarcoplasmic/endoplasmic reticulum Ca2+-ATPase activity and insulin sensitivity. To determine if the presence of metabolic syndrome alters specific phosphatidylcholine (PC) and phosphatidylethanolamine (PE) species in human SR, we compared SR phospholipid composition in skeletal muscle from sedentary subjects with metabolic syndrome and sedentary control subjects without metabolic syndrome. Both total PC and total PE were significantly decreased in skeletal muscle SR of sedentary metabolic syndrome patients compared with sedentary controls, particularly in female participants, but there was no difference in the PC:PE ratio between groups. Total SR PC levels, but not total SR PE levels or PC:PE ratio, were significantly negatively correlated with BMI, waist circumference, total fat, visceral adipose tissue, triglycerides, fasting insulin, and homeostatic model assessment for insulin resistance. These findings are consistent with the existence of a relationship between skeletal muscle SR PC content and insulin resistance in humans.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Endocrinology, Metabolism & Lipid Research, Washington University, St Louis, MO, USA.
- Division of Endocrinology, Metabolism & Lipid Research, Washington University, St Louis, MO, USA; Department of Cell Biology & Physiology, Washington University, St Louis, MO, USA. Electronic address: csemenko@wustl.edu.
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
- NIH
Zitieren
APA
Adamson, S. E., Adak, S., Petersen, M. C., Higgins, D., Spears, L. D., Zhang, R. M., Cedeno, A., McKee, A., Kumar, A., Singh, S., Hsu, F. F., McGill, J. B., & Semenkovich, C. F. (2024). Decreased sarcoplasmic reticulum phospholipids in human skeletal muscle are associated with metabolic syndrome. Journal of Lipid Research, 65(3), 100519. https://doi.org/10.1016/j.jlr.2024.100519
Vancouver
Adamson SE, Adak S, Petersen MC, Higgins D, Spears LD, Zhang RM, et al. Decreased sarcoplasmic reticulum phospholipids in human skeletal muscle are associated with metabolic syndrome. Journal of Lipid Research. 2024;65(3):100519. doi:10.1016/j.jlr.2024.100519
BibTeX
@article{Adamson2024,
author = {Adamson, Samantha E and Adak, Sangeeta and Petersen, Max C and Higgins, Dustin and Spears, Larry D and Zhang, Rong Mei and Cedeno, Andrea and McKee, Alexis and Kumar, Aswathi and Singh, Sudhir and Hsu, Fong-Fu and McGill, Janet B and Semenkovich, Clay F},
title = {Decreased sarcoplasmic reticulum phospholipids in human skeletal muscle are associated with metabolic syndrome},
journal = {Journal of Lipid Research},
year = {2024},
volume = {65},
number = {3},
pages = {100519},
doi = {10.1016/j.jlr.2024.100519}
}
EUVIMED